Samples were tested for the presence of AIs (2-androstenol (5-androst-2-en-17-ol), 2-androstenone (5-androst-2-en-17-one), 3-androstenol (5-androst-3-en-17-ol), 3-androstenone (5-androst-3-en-17-one), 4-androstene-3,6,17 trione (6-oxo), aminoglutethimide, anastrozole, androsta-1,4,6-triene-3,17-dione (androstatrienedione), androsta-3,5-diene-7,17-dione (arimistane), exemestane, formestane, letrozole, and testolactone), and anti-estrogenic substance (bazedoxifene, clomiphene, cyclofenil, fulvestrant, ospemifene, raloxifene, tamoxifen, and toremifene) prohibited by WADA
There is also a risk that prolonged use of BPC 157 could lead to severe health consequences, including the possibility of tumors or effects on fertility
Peptide dosing can be adjusted over time to match patient needs and treatment responses
When in doubt, starting fresh with a new vial is always safer than using questionable solution
[2] Women are more commonly affected than men
The synergy in these research combinations is based on their distinct yet complementary effects: BPC-157 is associated with localized tissue environmentstendon and ligament structures, gastrointestinal tissue, and muscle-tendon junctionsfocusing on vascular signaling, GHR interactions, and localized repair
